Transcatheter occlusion of complex atrial septal defects
- 30 August 2000
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 51 (1) , 33-41
Abstract
Percutaneous device occlusion of secundum atrial septal defects (ASDs) is becoming an accepted alternative to surgical closure. This method allows us to evaluate patients with complex conditions for treatment. From a total of 70 patients with ASD evaluated for percutaneous closure, we selected for analysis 28 who had complex conditions. The mean age was 36 ± 23 yr (range, 4–72). Six had heart failure, and of these six, three had atrial fibrillation. At cardiac catheterization, the pulmonary pressure was 47 ± 24 mm Hg, and the QP/QS was 1.7 ± 0.4; two patients had bidirectional shunt and systemic pulmonary pressure. Two patients received a buttoned device and 26 an Amplatzer septal occluder. The groups of patients with complex conditions were separated into the following groups. Group I (n = 4) underwent combined treatment of associated anomalies. Two patients had pulmonary stenosis, one had mitral stenosis, and one had an aortic root–left atrium fistula. They were treated in or during with the same procedure by combined transcatheter techniques (balloon valvuloplasty and fistula occlusion) before ASD occlusion. Group II (n = 9) had multiple defects (cribiform or two separate holes). They were treated with a single device in five instances and with two separate devices in four cases. Group III (n = 14) had large (32 ± 3 mm) single defects. Nine of them underwent successful implantation using a device 33 ± 3 mm in diameter; in the remaining five patients the device was removed because of instability. Group IV (n = 3) had residual defects after previous partial device occlusion. All three defects were successfully occluded with a second device. No movement or interference with the first device was observed. Group V (n = 6) had severe pulmonary hypertension (86 ± 16 mm Hg). Immediately after ASD occlusion we observed significant relief in these patients (67 ± 14 mm Hg; P < 0.01). There were no major complications; all 23 patients with successful implants were discharged without symptoms 2–7 days later; one patient with atrial fibrillation recovered sinus rhythm. The follow‐up (8 ± 5 mo) Doppler echo study showed complete ASD occlusion in 22 patients and a peak pulmonary pressure of 30 ± 14 mm Hg. We conclude that transcatheter occlusion of ASDs is an effective and safe treatment for patients with complex anatomic or physiopathologic conditions, as evaluated by short‐term follow‐up. Cathet. Cardiovasc. Intervent. 51:33–41, 2000.Keywords
This publication has 25 references indexed in Scilit:
- Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experienceHeart, 1999
- Echocardiographic characteristics of successful deployment of the Das AngelWings atrial septal defect closure device: initial multicenter experience in the United StatesThe American Journal of Cardiology, 1999
- Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal OccluderEuropean Heart Journal, 1999
- Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial)∗∗See Appendix for the list of participating institutions and investigators.The American Journal of Cardiology, 1998
- Multiple atrial septal defects and patent ductus arteriosus: Successful outcome using two Amplatzer™ septal occluders and Gianturco coilsCatheterization and Cardiovascular Diagnosis, 1998
- Closure of Atrial Septal Defects With the Amplatzer Occlusion Device: Preliminary ResultsJACC, 1998
- Intermediate-Term Results of Phase I Food and Drug Administration Trials of Buttoned Device Occlusion of Secundum Atrial Septal DefectsJACC, 1998
- International experience with secundum atrial septal defect occlusion by the buttoned deviceAmerican Heart Journal, 1994
- Atrial septal defect occlusion with the buttoned device (a multi-institutional U.S. trial)The American Journal of Cardiology, 1994
- Percutaneous closure of a secundum atrial septal defect and double balloon valvotomies of a severe mitral and aortic valve stenosis in a patient with lutembacher's syndrome and severe pulmonary hypertensionCatheterization and Cardiovascular Diagnosis, 1992